当前位置: X-MOL 学术Mol. Genet. Metab. Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria - Is nitisinone the solution?
Molecular Genetics and Metabolism Reports ( IF 1.8 ) Pub Date : 2020-04-16 , DOI: 10.1016/j.ymgmr.2020.100588
A S Davison 1, 2 , E Luangrath 1 , E Selvi 3 , L R Ranganath 1, 2
Affiliation  

Haemolysis and methaemoglobinaemia (MetHb) are rare metabolic complications that can occur in Alkaptonuria (AKU), for which there is no curative treatment. Presented is a case of a man who had AKU, and serves as a reminder of life-threatening complications that can occur with haemolysis and MetHb. This case presents an opportunity to revisit important considerations relating to the investigation and treatment of haemolysis and MetHb with a view to raising awareness, and in doing so hopefully reducing the uniformly fatal outcome. Additionally it is proposed that treatment of haemolysis and MetHb with nitisinone is considered as a potentially lifesaving treatment as it is believed that reducing the concentration of circulating homogentisic acid will reduce oxidative stress.



中文翻译:

患有肾功能衰竭和碱性磷酸酶尿症的人的致命性急性溶血和血红蛋白血症-尼替尼酮可以解决吗?

溶血和高铁血红蛋白血症(MetHb)是Alkaptonuria(AKU)中可能发生的罕见代谢并发症,目前尚无治疗方法。介绍的是一名患有AKU的男人的案例,它提醒人们溶血和MetHb可能发生危及生命的并发症。此案为重新认识与溶血和MetHb的研究和治疗有关的重要考虑提供了机会,以提高认识,并希望这样做可以减少一致的致命结果。另外,由于认为降低循环中的高纯酸的浓度将减少氧化应激,因此建议用尼替尼酮治疗溶血和MetHb是可能挽救生命的治疗方法。

更新日期:2020-04-16
down
wechat
bug